接种时间不影响健康老年人对肺炎球菌疫苗和年度流感疫苗的抗体应答
研究纳入140名50岁以上健康成人,比较上午与下午接种单剂PPV-23和季节性流感疫苗后的抗体应答。结果显示,接种时间对肺炎球菌和流感抗体应答均无显著影响,但 cohorts 中约18%对至少一种疫苗应答欠佳。
要点
- 上午与下午接种PPV-23后,肺炎球菌特异性抗体在1、4、52周均升高,但时间点无显著影响。
- 流感疫苗抗体应答在上午与下午组间无差异,H1N1基线免疫最高且第4周应答最强。
- 总队列中18%的受试者对肺炎球菌或流感疫苗应答欠佳。
核心结论
- 在50岁以上健康成人中,上午与下午接种PPV-23或季节性流感疫苗对短期和长期抗体应答均无显著影响。
研究设计与样本
- 研究纳入140名50岁以上健康成人,比较上午与下午接种单剂PPV-23和季节性流感疫苗后的抗体应答,于基线、接种后1、4、52周检测肺炎球菌血清型特异性抗体和血凝抑制试验抗体。
主要发现
- 上午组和下午组接种一剂PPV-23后,肺炎球菌特异性抗体在1、4、52周均升高,但接种时间对肺炎球菌抗体应答无显著影响。
- 肺炎球菌基线免疫较高(上午组57.1%、下午组50.0%达到WHO≥8/12PnPS),52周时至少7/12血清型抗体仍升高。
- 接种时间对流感短期或长期抗体应答均无影响;H1N1基线免疫最高(上午组67.6%、下午组48.6%达到≥40 HAI),第4周应答最高(上午组92.8%、下午组94.1%),52周时维持(上午组91.7%、下午组89.3%)。
- B/Victoria株在所有时间点的血清型免疫均最差。
- 总队列中18%的受试者对肺炎球菌或流感疫苗应答欠佳。
关键数值与推荐
- 肺炎球菌保护阈值设为0.35 μg/mL,需达到检测的12种血清型中至少8种(WHO≥8/12PnPS)。
- 流感保护阈值设为H1N1、H3N2和B/Victoria株血凝抑制抗体滴度≥40。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vaccines are less immunogenic in older adults, partly due to immunosenescence. Having previously shown that morning influenza vaccination may be more immunogenic in older adults (mean age 71), we assessed if this could be replicated in a younger cohort (mean age 57) and with a T-cell independent vaccine. This study examined whether diurnal timing of a single dose of Pneumovax® (PPV-23) and seasonal influenza vaccine influenced antibody responses in 140 healthy adults over the age of 50. Pneumococcal serotype-specific (PnPS) antibodies and Haemagglutination Inhibition Assays (HAI) were used to characterize antibody responses at Baseline, 1, 4, and 52 weeks post-vaccination. Protective thresholds were set at 0.35 μg/mL for two-thirds of PnPS tested (WHO≥8/12PnPS) and a titre of ≥40 HAI for H1N1, H3N2, and B/Victoria strains. Both AM and PM cohorts showed increased Pn-specific antibodies to one PPV-23 dose at weeks 1, 4, and 52; however, time of day did not significantly influence antibody responses. Baseline immunity for pneumococcus was high (57.1 % AM, 50.0 % PM had WHO≥8/12PnPS), and immunity was maintained with at least 7/12 serotypes elevated at 52 weeks. Time of day did not alter short- or long-term influenza antibody responses. H1N1 had the highest baseline immunity (67.6 % AM, 48.6 % PM had ≥40 HAI) and the most increased responses at week 4 post-vaccination (92.8 % AM, 94.1 % PM) that were maintained at 52 weeks post-vaccination (91.7 % AM, 89.3 % PM). The poorest serotype immunity was for the B/Victoria strain at all time points. Although time of day did not influence vaccine immunogenicity in AM and PM cohorts, sustained cohort-wide antibody responses were demonstrated in an older population. Identifying 18 % of the total cohort exhibited suboptimal responses to pneumococcal or influenza vaccines underscores the imperative for enhancing vaccine efficacy within this age group to reduce morbidity and mortality.
引用
- Faustini SE, Backhouse C, Duggal NA, et al. Time of day of vaccination does not influence antibody responses to pneumococcal and annual influenza vaccination in a cohort of healthy older adults. Vaccine. 2025. PMID: 39923601. doi:10.1016/j.vaccine.2025.126770
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。